65 results
6-K
EX-99.1
SCNI
Scinai Immunotherapeutics Ltd
25 Apr 24
Report of Foreign Private Issuer
4:00pm
leadership expertise World - class science & access to leading scientists NanoAb platform for the development of promising potent therapeutics Patents
6-K
EX-99.1
SCNI
Scinai Immunotherapeutics Ltd
16 Apr 24
Report of Foreign Private Issuer
5:27pm
biologics manufacturing facility Best - in - class equipped labs Top - tier big pharma & biotech leadership expertise World - class science & access
6-K
EX-99.1
SCNI
Scinai Immunotherapeutics Ltd
18 Jan 24
Report of Foreign Private Issuer
11:50am
- in - class equipped labs Top - tier big pharma & biotech leadership expertise World - class science & access to leading scientists NanoAb platform
6-K
EX-99.1
SCNI
Scinai Immunotherapeutics Ltd
9 Jan 24
Report of Foreign Private Issuer
8:45am
- in - class equipped labs Top - tier big pharma & biotech leadership expertise World - class science & access to leading scientists NanoAb platform
6-K
EX-1.1
SCNI
Scinai Immunotherapeutics Ltd
19 Sep 23
Report of Foreign Private Issuer
3:06pm
in conformity with GAAP and to maintain asset accountability, (iii) access to assets is permitted only in accordance with management’s general … and Data and to the protection of such IT Systems and Data from unauthorized use, access, misappropriation or modification, except as would
424B5
lyf afgxxj
19 Sep 23
Prospectus supplement for primary offering
10:03am
424B2
gz7a mc4qxng
28 Aug 23
Prospectus for primary offering
4:01pm
6-K
EX-99.1
wv6i 7o9gqmy
23 Aug 23
Report of Foreign Private Issuer
6:10am
F-3
m8dn ng9tenx
18 Aug 23
Shelf registration (foreign)
4:16pm
6-K
EX-99.1
w27tz40gc3mx
5 Jul 23
Report of Foreign Private Issuer
9:28am
10-Q
d0iq0yuxgbs4cq u5fd1
15 May 23
Quarterly report
4:49pm
8-K
EX-99.1
froi66ep jsgwrnb4
4 May 23
Regulation FD Disclosure
9:25am
10-K
EX-14.1
z0jii17x xp6
17 Apr 23
Annual report
4:06pm
10-K
EX-4.1
wsy6x37h9ilfzac 2we
17 Apr 23
Annual report
4:06pm
10-K
7e49eg0h88q s3z
17 Apr 23
Annual report
4:06pm
6-K
EX-99.1
u3rxu7wi691c7k
29 Dec 22
Report of Foreign Private Issuer
10:39am
6-K
EX-1.1
ukswfnkwbtca
20 Dec 22
BiondVax Announces Closing of $8 Million Underwritten Public Offering
5:29pm
424B4
ztlwxqgd0y75
20 Dec 22
Prospectus supplement with pricing info
11:59am
F-1/A
EX-1.1
n8c5t7 grg3
14 Dec 22
Registration statement (foreign) (amended)
4:45pm
F-1/A
voh6dj5
12 Dec 22
Registration statement (foreign) (amended)
5:25pm